Voyager Therapeutics (VYGR) Prepaid Assets (2014 - 2026)
Voyager Therapeutics (VYGR) reported Prepaid Assets of $3.9 million for Q1 2026, down 45.5% on a YoY basis from $7.1 million in Q1 2025, and down 10.88% sequentially from $4.3 million in Q4 2025.
Voyager Therapeutics (VYGR) Prepaid Assets (2014 - 2026) Analysis & Trends
Voyager Therapeutics (VYGR) has 13 years of Prepaid Assets data on file, last reported at $3.9 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 45.5% year-over-year to $3.9 million; the trailing twelve-month figure through Mar 2026 stood at $3.9 million (down 45.5% YoY), and the FY2025 full-year result was $4.3 million, down 45.53% from the prior year.
- Prepaid Assets fell to $3.9 million in Q1 2026, from $4.3 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $9.8 million in Q2 2025 to a low of $3.4 million in Q2 2022.
- A 5-year average of $5.9 million and a median of $5.7 million in 2023 frame the typical range for Prepaid Assets.
- Peak annual rise in Prepaid Assets reached 296.62% in 2022, while the deepest fall reached 64.16% in 2022.
- Tracing VYGR's Prepaid Assets over 5 years: stood at $5.4 million in 2022, then dropped by 1.41% to $5.3 million in 2023, then surged by 49.4% to $7.9 million in 2024, then plunged by 45.53% to $4.3 million in 2025, then slipped by 10.88% to $3.9 million in 2026.
- Business Quant data shows VYGR's Prepaid Assets at $3.9 million in Q1 2026, $4.3 million in Q4 2025, and $6.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Voyager Therapeutics | 183.84 Mn | 42.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.86 Mn |
| Dec 31, 2025 | 4.33 Mn |
| Sep 30, 2025 | 6.62 Mn |
| Jun 30, 2025 | 9.77 Mn |
| Mar 31, 2025 | 7.08 Mn |
| Dec 31, 2024 | 7.95 Mn |
| Sep 30, 2024 | 8.42 Mn |
| Jun 30, 2024 | 7.30 Mn |
| Mar 31, 2024 | 6.11 Mn |
| Dec 31, 2023 | 5.32 Mn |
| Sep 30, 2023 | 5.74 Mn |
| Jun 30, 2023 | 6.08 Mn |
| Mar 31, 2023 | 3.98 Mn |
| Dec 31, 2022 | 5.39 Mn |
| Sep 30, 2022 | 5.08 Mn |
| Jun 30, 2022 | 3.42 Mn |
| Mar 31, 2022 | 3.61 Mn |
| Dec 31, 2021 | 1.36 Mn |
| Sep 30, 2021 | 3.54 Mn |
| Jun 30, 2021 | 3.91 Mn |